Recognizing the potential for copper-related toxicities from liposomal daunorubicin--cytarabine.

Subjects

Subjects :

Antineoplastic Combined Chemotherapy Protocols
Copper therapeutic use
Daunorubicin adverse effects
Humans
Cytarabine adverse effects
Leukemia, Myeloid, Acute drug therapy

Details

Language :

English

ISSN :

1477-092X

Volume :

27

Issue :

3

Database :

MEDLINE

Journal :

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Publication Type :

Editorial & Opinion

Accession number :

33593136

Full Text :

https://doi.org/10.1177/1078155221994322